188 related articles for article (PubMed ID: 33799127)
1. Incidence and investigation of potential risk-factors for clozapine-associated myocarditis and cardiomyopathy in a New Zealand cohort.
Bellissima BL; Vara A; Helsby N; Garavan F; Tingle MD
Psychiatry Res; 2021 May; 299():113873. PubMed ID: 33799127
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors for clozapine-induced myocarditis and cardiomyopathy at a regional mental health service in Australia.
Youssef DL; Narayanan P; Gill N
Australas Psychiatry; 2016 Apr; 24(2):176-80. PubMed ID: 26400457
[TBL] [Abstract][Full Text] [Related]
3. [Reaction on 'Myocarditis and cardiomyopathy underestimated complications resulting from clozapine therapy'].
Cohen D
Tijdschr Psychiatr; 2010; 52(10):727-8; author reply 728-9. PubMed ID: 20931487
[No Abstract] [Full Text] [Related]
4. Systematic review and meta-analysis of rates of clozapine-associated myocarditis and cardiomyopathy.
Siskind D; Sidhu A; Cross J; Chua YT; Myles N; Cohen D; Kisely S
Aust N Z J Psychiatry; 2020 May; 54(5):467-481. PubMed ID: 31957459
[TBL] [Abstract][Full Text] [Related]
5. [Reaction on 'Myocarditis and cardiomyopathy underestimated complications resulting from clozapine therapy'].
Schulte PF
Tijdschr Psychiatr; 2011; 53(3):193-4. PubMed ID: 21404176
[No Abstract] [Full Text] [Related]
6. [Myocarditis and cardiomyopathy: underestimated complications resulting from clozapine therapy].
Kamphuis H; Arends J; Timmerman L; van Marle J; Kappert J
Tijdschr Psychiatr; 2010; 52(4):223-33. PubMed ID: 20503163
[TBL] [Abstract][Full Text] [Related]
7. Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service.
Reinders J; Parsonage W; Lange D; Potter JM; Plever S
Aust N Z J Psychiatry; 2004; 38(11-12):915-22. PubMed ID: 15555025
[TBL] [Abstract][Full Text] [Related]
8. Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014.
Hollingworth SA; Winckel K; Saiepour N; Wheeler AJ; Myles N; Siskind D
Psychopharmacology (Berl); 2018 Jul; 235(7):1915-1921. PubMed ID: 29589067
[TBL] [Abstract][Full Text] [Related]
9. Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring Programme.
Hill GR; Harrison-Woolrych M
N Z Med J; 2008 Oct; 121(1283):68-75. PubMed ID: 18841187
[TBL] [Abstract][Full Text] [Related]
10. Chart review for potential features of myocarditis, pericarditis, and cardiomyopathy in children and adolescents treated with clozapine.
Wehmeier PM; Schüler-Springorum M; Heiser P; Remschmidt H
J Child Adolesc Psychopharmacol; 2004; 14(2):267-71. PubMed ID: 15319023
[TBL] [Abstract][Full Text] [Related]
11. Myocarditis and cardiomyopathy associated with clozapine.
Kilian JG; Kerr K; Lawrence C; Celermajer DS
Lancet; 1999 Nov; 354(9193):1841-5. PubMed ID: 10584719
[TBL] [Abstract][Full Text] [Related]
12. Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine.
Wehmeier PM; Heiser P; Remschmidt H
J Clin Pharm Ther; 2005 Feb; 30(1):91-6. PubMed ID: 15659009
[TBL] [Abstract][Full Text] [Related]
13. Incidence and Management of Clozapine-Induced Myocarditis in a Large Tertiary Hospital.
Higgins JM; San C; Lagnado G; Chua D; Mihic T
Can J Psychiatry; 2019 Aug; 64(8):561-567. PubMed ID: 30599763
[TBL] [Abstract][Full Text] [Related]
14. Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review.
Knoph KN; Morgan RJ; Palmer BA; Schak KM; Owen AC; Leloux MR; Patel M; Leung JG
Schizophr Res; 2018 Sep; 199():17-30. PubMed ID: 29548760
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for clozapine-induced myocarditis and cardiomyopathy: A systematic review and meta-analysis.
Vickers M; Ramineni V; Malacova E; Eriksson L; McMahon K; Moudgil V; Scott J; Siskind D
Acta Psychiatr Scand; 2022 May; 145(5):442-455. PubMed ID: 35067911
[TBL] [Abstract][Full Text] [Related]
16. Update on the adverse effects of clozapine: focus on myocarditis.
De Berardis D; Serroni N; Campanella D; Olivieri L; Ferri F; Carano A; Cavuto M; Martinotti G; Cicconetti A; Piersanti M; Saverio Moschetta F; Di Giannantonio M
Curr Drug Saf; 2012 Feb; 7(1):55-62. PubMed ID: 22663959
[TBL] [Abstract][Full Text] [Related]
17. Myocarditis and cardiomyopathy associated with clozapine use in the United States.
La Grenade L; Graham D; Trontell A
N Engl J Med; 2001 Jul; 345(3):224-5. PubMed ID: 11463031
[No Abstract] [Full Text] [Related]
18. Adverse cardiac effects associated with clozapine.
Merrill DB; Dec GW; Goff DC
J Clin Psychopharmacol; 2005 Feb; 25(1):32-41. PubMed ID: 15643098
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic clozapine (Clozaril): myocarditis and cardiovascular toxicity.
Wooltorton E
CMAJ; 2002 Apr; 166(9):1185-6. PubMed ID: 12000254
[No Abstract] [Full Text] [Related]
20. Early recognition of clozapine-induced myocarditis.
Annamraju S; Sheitman B; Saik S; Stephenson A
J Clin Psychopharmacol; 2007 Oct; 27(5):479-83. PubMed ID: 17873680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
